prikaz prve stranice dokumenta Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma
Rad nije dostupan
Znanstveni rad - Izvorni znanstveni rad
Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma
Applied immunohistochemistry & molecular morphology, 29 (2021), 8; 576-584. https://doi.org/10.1097/pai.0000000000000932


Citirajte ovaj rad

Marijić, B., Braut, T., Babarović, E., Krstulja, M., Maržić, D., Avirović, M. ... Hadžisejdić, I. (2021). Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma. Applied immunohistochemistry & molecular morphology, 29. (8), 576-584. doi: 10.1097/pai.0000000000000932

Marijić, Blažen, et al. "Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma." Applied immunohistochemistry & molecular morphology, vol. 29, br. 8, 2021, str. 576-584. https://doi.org/10.1097/pai.0000000000000932

Marijić, Blažen, Tamara Braut, Emina Babarović, Mira Krstulja, Diana Maržić, Manuela Avirović, Milodar Kujundžić i Ita Hadžisejdić. "Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma." Applied immunohistochemistry & molecular morphology 29, br. 8 (2021): 576-584. https://doi.org/10.1097/pai.0000000000000932

Marijić, B., et al. (2021) 'Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma', Applied immunohistochemistry & molecular morphology, 29(8), str. 576-584. doi: 10.1097/pai.0000000000000932

Marijić B, Braut T, Babarović E, Krstulja M, Maržić D, Avirović M, i sur.. Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma. Applied immunohistochemistry & molecular morphology [Internet]. 2021. [pristupljeno 17.04.2024.];29(8):576-584. doi: 10.1097/pai.0000000000000932

B. Marijić, et al., "Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma", Applied immunohistochemistry & molecular morphology, vol. 29, br. 8, str. 576-584, 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:567689. [Citirano: 17.04.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.